SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-082017
Filing Date
2022-07-22
Accepted
2022-07-22 16:30:47
Documents
5
Period of Report
2022-09-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2220750-2_def14a.htm DEF 14A 586357
2 GRAPHIC sg_dietrichstephannew-bw.jpg GRAPHIC 5881
3 GRAPHIC lg_neubase-bwlr.jpg GRAPHIC 18968
4 GRAPHIC tm2220750d1-px_proxy1bw.jpg GRAPHIC 934325
5 GRAPHIC tm2220750d1-px_proxy2bw.jpg GRAPHIC 705938
  Complete submission text file 0001104659-22-082017.txt   2877370
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35963 | Film No.: 221100241
SIC: 2834 Pharmaceutical Preparations